Rates and Implications for Hospitalization of Patients ≥65 Years of Age With Atrial Fibrillation/Flutter

被引:40
作者
Naccarelli, Gerald V. [1 ]
Johnston, Stephen S. [2 ]
Dalal, Mehul [3 ]
Lin, Jay [4 ]
Patel, Parag P. [1 ]
机构
[1] Penn State Univ, Milton S Hershey Med Ctr, Penn State Heart & Vasc Inst, Hershey, PA 17033 USA
[2] Thomson Reuters, Washington, DC USA
[3] Sanofi Aventis, Bridgewater, NJ USA
[4] Novosys Hlth, Flemington, NJ USA
关键词
RISK-FACTORS; STROKE; POPULATION; PREVENTION; PREVALENCE; IMPACT; COSTS;
D O I
10.1016/j.amjcard.2011.10.009
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The responsibility of managing atrial fibrillation (AF) and atrial flutter (AFL) falls predominantly on the Medicare system. Patients with AF or AFL often have a range of cardiovascular (CV) co-morbidities and are frequently hospitalized for AF and other CV causes. The present retrospective cohort study used medical claims data to evaluate the rates of hospitalization and inpatient mortality in elderly (aged >= 65 years) patients with AF or AFL with Medicare supplemental insurance. The data were extracted from the United States Thomson Reuters Market Scan Medicare Supplemental and Coordination of Benefits Database (January 2004 to December 2007). Patients aged >= 65 years with >= 1 inpatient or >= 2 outpatient nondiagnostic claims for AF or AFL and >= 12 months of continuous enrollment before their index AF or AFL diagnoses were identified. The frequencies of hospitalization and inpatient death were evaluated over the postindex study period (mean 24.3 months). Of an eligible study population of 55,774 patients with AF or AFL (mean age 77.9 years, 52.2% men), 28,939 patients (51.9%) were hospitalized (all causes) with nonfatal outcomes, 12,652 (22.7%) were rehospitalized, and 1,592 (2.9%) died in the hospital. Higher proportions of patients were hospitalized for non-CV than for CV causes (35.6% vs 27.2%). For CV hospitalizations culminating in inpatient death (n = 516), the most common admission diagnoses were major bleeding, stroke or transient ischemic attack, and congestive heart failure. In conclusion, elderly patients with AF or AFL undergo frequent hospitalization for CV and non-CV causes. Measures that lower inpatient admission rates, particularly readmission rates, may reduce the increasing cost of treating patients with AF or AFL with Medicare supplemental insurance. (C) 2012 Elsevier Inc. All rights reserved. (Am J Cardiol 2012;109:543-549)
引用
收藏
页码:543 / 549
页数:7
相关论文
共 26 条
[1]  
[Anonymous], 2009, MARKETSCAN STUD ABBR
[2]  
[Anonymous], HOSP HOM RED READM I
[3]   Impact of atrial fibrillation on the risk of death [J].
Benjamin, EJ ;
Wolf, PA ;
D'Agostino, RB ;
Silbershatz, H ;
Kannel, WB ;
Levy, D .
CIRCULATION, 1998, 98 (10) :946-952
[4]   A NEW METHOD OF CLASSIFYING PROGNOSTIC CO-MORBIDITY IN LONGITUDINAL-STUDIES - DEVELOPMENT AND VALIDATION [J].
CHARLSON, ME ;
POMPEI, P ;
ALES, KL ;
MACKENZIE, CR .
JOURNAL OF CHRONIC DISEASES, 1987, 40 (05) :373-383
[5]   Assessing the direct costs of treating nonvalvular atrial fibrillation in the United States [J].
Coyne, Karin S. ;
Paramore, Clark ;
Grandy, Susan ;
Mercader, Marco ;
Reynolds, Matthew ;
Zimetbaum, Peter .
VALUE IN HEALTH, 2006, 9 (05) :348-356
[6]   Validation of clinical classification schemes for predicting stroke - Results from the national registry of Atrial Fibrillation [J].
Gage, BF ;
Waterman, AD ;
Shannon, W ;
Boechler, M ;
Rich, MW ;
Radford, MJ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (22) :2864-2870
[7]   Prevalence of diagnosed atrial fibrillation in adults - National implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) study [J].
Go, AS ;
Hylek, EM ;
Phillips, KA ;
Chang, YC ;
Henault, LE ;
Selby, JV ;
Singer, DE .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (18) :2370-2375
[8]  
Hansen LG., 2009, Health Research Data for the real world: The MarketScan Databases. A white paper
[9]   Rationale and design of ATHENA: A placebo-controlled, double-blind, parallel arm trial to assess the efficacy of dronedarone 400 mg bid for the prevention of cardiovascular hospitalization or death from any cause in PatiENts with atrial fibrillation/atrial flutter [J].
Hohnloser, Stefan H. ;
Connolly, Stuart J. ;
Crijns, Harry J. G. M. ;
Page, Richard L. ;
Seiz, Werner ;
Torp-Petersen, Christian .
JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2008, 19 (01) :69-73
[10]   Stroke and thromboembolism in atrial fibrillation: A systematic review of stroke risk factors, risk stratification schema and cost effectiveness data [J].
Hughes, Michael ;
Lip, Gregory Y. H. .
THROMBOSIS AND HAEMOSTASIS, 2008, 99 (02) :295-304